asparaginase erwinia chrysanthemi (recombinant)-rywn

CHEBI:CHEBI_752255

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

active_ingredient_name
ASPARAGINASE
rxcui
2561256
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20251231
dosage_form
INJECTION
route
INTRAMUSCULAR
active_ingredient_strength
20 mg/mL
marketing_category
BLA
marketing_start_date
20210630
package_marketing_start_date
20210630
labeler_name
Jazz Pharmaceuticals, Inc.
manufacturer_name
Jazz Pharmaceuticals, Inc.
generic_name
asparaginase erwinia chrysanthemi (recombinant)-rywn
brand_name
Rylaze
brand_name_base
Rylaze
product_ndc
68727-900
application_number
BLA761179
spl_id
bbc1b12f-681b-4d2b-abe2-bc1c82077744
package_ndc
68727-900-03
package_description
3 VIAL, SINGLE-DOSE in 1 CARTON (68727-900-03) / .5 mL in 1 VIAL, SINGLE-DOSE (68727-900-01)
unii
G4FQ3CKY5R
spl_set_id
857e53aa-1098-4dad-b654-0276cdd43e03
nui
N0000175669
pharm_class_epc
Asparagine-specific Enzyme [EPC]
pharm_class
Asparaginase [CS]
pharm_class_cs
Asparaginase [CS]
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class